DocMode Health Technologies delays FY26 results, appoints compliance officer
DocMode Health Technologies has delayed its audited financial results for FY26, citing emergency leave of key personnel. The Board appointed Ms. Juhi Tanna (ACS-59864) as Whole Time Company Secretary and Compliance Officer effective May 30, 2026, and re-appointed M/s. Vidhi Jobanputra & Co. as Secretarial Auditor for FY 2025-26 and M/s. C.J.K. Associates (FRN: 117467W) as Internal Auditor for FY 2026-27.

*this image is generated using AI for illustrative purposes only.
DocMode Health Technologies has announced a delay in the submission of its audited standalone and consolidated financial results for the half-year and financial year ended March 31, 2026. The company cited the unexpected emergency leave of key personnel responsible for finalizing financial statements as the reason for the incomplete audit. Consequently, the auditors are currently unable to complete the audit and issue the signed financial results, which were required to be submitted to the stock exchanges by May 30, 2026, under Regulation 33 of the SEBI Listing Regulations.
Appointment of Key Managerial Personnel
The Board of Directors, based on the recommendations of the Nomination and Remuneration Committee, approved the appointment of Ms. Juhi Tanna as Whole Time Company Secretary and Compliance Officer, effective May 30, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Tanna is an Associate Member of the Institute of Company Secretaries of India with Membership Number 59864. She holds a Bachelor of Commerce and a Bachelor of Law degree, and brings with her a sound understanding of secretarial compliances and corporate governance. She will also serve as Key Managerial Personnel under Section 203 of the Companies Act, 2013, and under Regulation 30(5) of the SEBI LODR Regulations for determining the materiality of any event or transaction for making required disclosures to the stock exchange. The company confirmed that she is not related to any directors or key managerial personnel of the company.
The following table summarises the key details of Ms. Tanna's appointment:
| Particulars: | Details |
|---|---|
| Name: | Ms. Juhi Tanna |
| Designation: | Whole Time Company Secretary & Compliance Officer |
| ICSI Membership No.: | ACS - 59864 |
| Date of Appointment: | May 30, 2026 |
| Qualification: | B.Com, Bachelor of Law |
| Relationship with Directors/KMP: | Not related |
Board Approvals and Auditor Appointments
At its meeting held on May 30, 2026, the Board of Directors also approved the re-appointment of statutory auditors and internal auditors. M/s. Vidhi Jobanputra & Co., Practicing Company Secretary, was re-appointed as the Secretarial Auditor for the financial year 2025-26 in compliance with Section 204 of the Companies Act, 2013. M/s. C.J.K. Associates, Chartered Accountants, was re-appointed as the Internal Auditor for the financial year 2026-27 under Section 138 of the Companies Act, 2013. The firm registration number for M/s. C.J.K. Associates is 117467W.
Auditor Details
| Particulars: | Details |
|---|---|
| Secretarial Auditor: | M/s. Vidhi Jobanputra & Co. |
| Term for Secretarial Auditor: | FY 2025-26 |
| Internal Auditor: | M/s. C.J.K. Associates (FRN: 117467W) |
| Term for Internal Auditor: | FY 2026-27 |
The company stated that it is committed to completing the pending work and submitting the audited half-yearly and annual financial results at the earliest. Prior intimation regarding the subsequent Board meeting to finalize the results will be made soon.
Historical Stock Returns for Docmode Health Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | +4.64% | -45.68% | -29.42% | -73.20% |
What potential penalties or regulatory actions might SEBI impose for the delay in submitting the audited financial results?
How will the market react to the delay in financial results, and could it impact investor confidence in DocMode Health Technologies?
What measures is the company taking to ensure that the absence of key personnel does not lead to further delays in future financial reporting?


























